SCHEMBL6049572

SCHEMBL6049572

CC(C)(C)c1cc(N(C(N)=O)c2ccc(Cc3ccncc3)cc2)c(C(=O)O)s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.36
RAF1 P04049 1/20 0.35
MAPK14 Q16539 3/20 0.34
ERBB2 P04626 1/20 0.34
MAPK11 Q15759 1/20 0.34
TSHR P16473 1/20 0.34
COPS5 Q92905 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
RAB9A P51151 2/20 0.33
POLB P06746 2/20 0.33
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
LMNA P02545 2/20 0.32
HTT P42858 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7624240 0.82 RAF1 (0.40) RAF1MAPK14RAB9AGAANPSR1
SCHEMBL3630059 0.78 CYP17A1 (0.39) CYP17A1RAF1MAPK14ERBB2MAPK11
SCHEMBL13388916 0.72 MEN1 (0.47) CYP17A1MEN1KMT2ARAB9APOLB
SCHEMBL27608792 0.71 CYP17A1 (0.49) CYP17A1TSHRMEN1KMT2ARAB9A
SCHEMBL27608860 0.71 CYP17A1 (0.49) CYP17A1TSHRMEN1KMT2ARAB9A
SCHEMBL667391 0.71 MAPK14 (0.62) RAF1MAPK14ERBB2MAPK11MEN1
SCHEMBL6049566 0.70 MAPK14 (0.43) CYP17A1RAF1MAPK14ERBB2MAPK11
SCHEMBL4429666 0.70 RAF1 (0.52) RAF1MAPK14MAPK11
SCHEMBL27842253 0.70 MAPK14 (0.54) CYP17A1RAF1MAPK14ERBB2MAPK11
SCHEMBL27608750 0.69 ESR1 (0.47) CYP17A1TSHRMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1041982-A4 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS BAYER PHARMACEUTICALS CORP (US) 2006-06-14 EP disclosed
EP-1041982-A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS Bayer Corporation (US) 2000-10-11 EP disclosed
WO-1999032111-A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS BAYER CORPORATION (US) 1999-07-01 WO disclosed